May 21, 2022 Comments Off on New patent for Janssen Pharms drug SPRAVATO Posted in: Patent Added Annual Drug Patent Expirations for SPRAVATO Spravato is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. There are four patents…
The post New patent for Janssen Pharms drug SPRAVATO appeared first on Drug…
May 21, 2022 Comments Off on New patent for Astrazeneca drug SYMBICORT Posted in: Patent Added Annual Drug Patent Expirations for SYMBICORT Symbicort is a drug marketed by Astrazeneca and is included in one NDA. It is available from three suppliers. There are ten patents protecting…
The post New patent for Astrazeneca drug SYMBICORT appeared fir…